Garheng Kong's Net Worth

$3.16 Million

Estimate Recalculated Mar 25, 2025 06:08PM EST

Who is Garheng Kong?

Garheng Kong has an estimated net worth of $3.16 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, LABORATORY CORP OF AMERICA HOLDINGS, Venus Concept Inc., CEMPRA, INC., HISTOGENICS CORP, CASTLE BIOSCIENCES INC, Xeris Biopharma Holdings, Inc., Strongbridge Biopharma plc, ALIMERA SCIENCES INC, and American Oncology Network, Inc..

SEC CIK

Garheng Kong's CIK is 0001435183

Past Insider Trading and Trends

2021 was Garheng Kong's most active year for acquiring shares with 18 total transactions. Garheng Kong's most active month to acquire stocks was the month of January. 2021 was Garheng Kong's most active year for disposing of shares, totalling 5 transactions. Garheng Kong's most active month to dispose stocks was the month of January. 2015 saw Garheng Kong paying a total of $49,335.39 for 63,570 shares, this is the most they've acquired in one year. In 2020 Garheng Kong cashed out on 20,271 shares for a total of $54,465.84, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.44M
—
—
0
Nov 21
Form 4
—
0
—
—
0
Jun 14
Form 4
+1,212.01%
1.33M
$14.00
—
1.44M
Feb 19
Form 3
—
0
—
—
0
No matching records found

LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.65%
947
—
—
11.9K
Feb 6 - Feb 7
Form 4
+7.27%
742
—
—
10.95K
Feb 11
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 11
Form 4
+8.17%
771
—
—
10.21K
Feb 2
Form 4
+11.67%
986
—
—
9.44K
Feb 4
Form 4
—
0
—
—
0
Feb 2
Form 4
+16.98%
1.23K
—
—
8.45K
Feb 12
Form 4
—
0
—
—
0
Feb 4
Form 4
+16.78%
1.04K
—
—
7.22K
Feb 12
Form 4
—
0
—
—
0
Feb 12
Form 4
+25.65%
1.26K
—
—
6.19K
Feb 7
Form 4
+46.37%
1.56K
—
—
4.92K
Feb 9
Form 4
—
0
—
—
0
Feb 7
Form 4
+58.16%
1.24K
—
—
3.36K
Mar 11
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Mar 11
Form 4
+240.87%
1.5K
—
—
2.13K
Feb 10
Form 4
∞
624
—
—
624
Dec 2
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found

Venus Concept Inc. (VERO) Snapshot price: $0.53

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 24
Form 4
—
0
—
—
0
Nov 18
Form 4
—
0
—
—
0
Mar 25
Form 4
+30.80%
1.6M
$1.25
$2,000,000.00
6.8M
Dec 15
Form 4
—
0
—
—
0
Mar 26
Form 4
+30.03%
1.2M
—
—
5.2M
Jun 16
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Mar 18
Form 4
∞
4M
$3.75
—
4M
Nov 7
Form 3
—
0
—
—
0
No matching records found

MELINTA THERAPEUTICS, INC. /NEW/ No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 1
Form 4
∞
2.83K
$17.43
$49,335.39
2.83K
Oct 26
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Mar 20
Form 3
—
0
—
—
0
No matching records found

HISTOGENICS CORP (OCGN) Snapshot price: $1.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
—
—
0
Jun 24
Form 3
—
0
—
—
0
No matching records found